Skip to main content
Antipsychotic safe, effective for resistant depression in phase 3 trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Antipsychotic safe, effective for resistant depression in phase 3 trial
User login
Username
Password
Reset your password
Concept
Lead
score
Depression
1
1
Antidepressant drug
0
1
Cyclic Antidepressants
0
0.71
Atypical Antipsychotics
0
1
Antipsychotics
0
0.2
Dopamine
0
0.2
Food and Drug Administration (FDA)
0
0.2
Hospital
0
0.2
Massachusetts
0
0.2
Receptors
0
0.2
Anxiety
0
0.1
Europe
0
0.1
Kidney
0
0.1
Major Depression
0
0.1
Mania
0
0.1
Match
0
0.1
Mental Illness
0
0.1
Nausea
0
0.1
New York
0
0.1
Quality Control (QC)
0
0.1
Selective Serotonin-Reuptake Inhibitors
0
0.1
SNRI
0
0.1
Stress
0
0.1
Anxiety Disorder
0
0.08
Medical Life
0
0.08
Multiple Sclerosis
0
0.08
Schizophrenia
0
0.08
Specialty
Lead
score
Psychiatry
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Pharmacist
0
1
Medscape Today
0
0.19
Hospital Medicine
0
0.16
Neurology & Neurosurgery
0
0.13
Nephrology
0
0.08
Edit Tags